The pharmaceutical company introduces its new weight loss medication in the British market.
Eli Lilly has launched its weight loss pill Foundayo in the United Kingdom. The company did not provide additional details on pricing or distribution in its announcement.
Further specifics about the pill’s availability or market impact were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
